Literature DB >> 34504725

Clinical Characteristics, Molecular Profile, and Outcomes in Indian Patients with Glutaric Aciduria Type 1.

Parag M Tamhankar1,2,3, Lakshmi Vasudevan1, Pratima Kondurkar1, Sarfaraj Niazi4, Rita Christopher5, Dhaval Solanki6, Pooja Dholakia7, Mamta Muranjan8, Mahesh Kamate9, Umesh Kalane10, Jayesh Sheth11, Vasundhara Tamhankar2, Reena Gulati12, Madhavi Vasikarla13, Sumita Danda14, Shaik M Naushad3, Katta M Girisha15, Shekhar Patil16.   

Abstract

Glutaric acidemia type 1 (GA-1, OMIM 231670) is an autosomal recessive inborn error of metabolism caused by the deficiency of glutaryl-coenzyme A (CoA) dehydrogenase with most children presenting in infancy with encephalopathy, dystonia, and macrocephaly. In this article, we presented the clinical characteristics, molecular profile, and outcomes in 29 unrelated families with affected children (30 cases total). The mean age at onset of illness was 10 months (±14.58), whereas the mean age at referral for molecular diagnosis was 29.44 months (±28.11). Patients were residents of nine different states of India. Clinical presentation varied from acute encephalitis followed by neuroregression and chronic/insidious developmental delay. Neurological sequelae varied from asymptomatic (no sequelae, 2 patients) to moderate (5 patients) and severe (23 patients) sequelae. All patients underwent blood tandem mass spectrometry (TMS on dried blood spots) and/or urine gas chromatography mass spectrometry (GCMS). Neuroimaging demonstrated batwing appearance in 95% cases. Sanger's sequencing of GCDH , covering all exons and exon-intron boundaries, was performed for all patients. Variants identified include 15 novel coding variants: p.Met100Thr, p.Gly107Ser, p.Leu179Val, p.Pro217Ser, p. Phe236Leufs*107, p.Ser255Pro, p.Met266Leufs*2, p.Gln330Ter, p.Thr344Ile, p.Leu345Pro, p.Lys377Arg, p.Leu424Pro, p.Asn373Lys, p.Lys377Arg, p.Asn392Metfs*9, and nine known genetic variants such as p.Arg128Gln, p.Leu179Arg, p.Trp225Ter, p.Met339Val, p.Gly354Ser, p.Arg402Gln, p.Arg402Trp, p.His403Tyr, and p.Ala433Val (Ensembl transcript ID: ENST00000222214). Using in silico analysis, genetic variants were shown to be affecting the residues responsible for homotetramer formation of the glutaryl-CoA dehydrogenase protein. Treatment included oral carnitine, riboflavin, protein-restricted diet, lysine-deficient special formulae, and management of acute crises with intravenous glucose and hydration. However, the mortality (9/30, 27.58%) and morbidity was high in our cohort with only two patients affording the diet. Our study is the largest multicentric, genetic variant-proven series of glutaric aciduria type 1 from India till date. Thieme. All rights reserved.

Entities:  

Keywords:  GCDH; glutaric aciduria; in silico; novel; variant

Year:  2020        PMID: 34504725      PMCID: PMC8416222          DOI: 10.1055/s-0040-1715528

Source DB:  PubMed          Journal:  J Pediatr Genet        ISSN: 2146-460X


  28 in total

1.  Pathogenic mutations in the carboxyl-terminal domain of glutaryl-CoA dehydrogenase: effects on catalytic activity and the stability of the tetramer.

Authors:  Jonna B Westover; Stephen I Goodman; Frank E Frerman
Journal:  Mol Genet Metab       Date:  2003-08       Impact factor: 4.797

2.  Atypical Glutaric Aciduria Type I with Hemidystonia and Asymmetric Radiological Findings Misdiagnosed as an Ischemic Stroke.

Authors:  Diane Demailly; Christine Vianey-Saban; Cécile Acquaviva; Victoria Gonzalez; Isabel De Antonio Rubio; Fabienne Cyprien; Thomas Roujeau; Adria Masoliver; Nicolas Leboucq; Philippe Coubes; Laura Cif
Journal:  Mov Disord Clin Pract       Date:  2018-07-19

Review 3.  Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision.

Authors:  Nikolas Boy; Chris Mühlhausen; Esther M Maier; Jana Heringer; Birgit Assmann; Peter Burgard; Marjorie Dixon; Sandra Fleissner; Cheryl R Greenberg; Inga Harting; Georg F Hoffmann; Daniela Karall; David M Koeller; Michael B Krawinkel; Jürgen G Okun; Thomas Opladen; Roland Posset; Katja Sahm; Johannes Zschocke; Stefan Kölker
Journal:  J Inherit Metab Dis       Date:  2016-11-16       Impact factor: 4.982

4.  Genetic Screening of Selected Disease-Causing Mutations in Glutaryl-CoA Dehydrogenase Gene among Indian Patients with Glutaric Aciduria Type I.

Authors:  Kruthika-Vinod Tp; Shaik Muntaj; K S Devaraju; M Kamate; A B Vedamurthy
Journal:  J Pediatr Genet       Date:  2017-03-07

5.  Molecular and biochemical study of glutaric aciduria type 1 in 49 Russian families: nine novel mutations in the GCDH gene.

Authors:  Marina V Kurkina; Svetlana V Mihaylova; Galina V Baydakova; Elena V Saifullina; Sergey A Korostelev; Denis V Pyankov; Ilya V Kanivets; Maksim A Yunin; Natalya L Pechatnikova; Ekaterina Y Zakharova
Journal:  Metab Brain Dis       Date:  2020-04-02       Impact factor: 3.584

6.  Crystal structures of human glutaryl-CoA dehydrogenase with and without an alternate substrate: structural bases of dehydrogenation and decarboxylation reactions.

Authors:  Zhuji Fu; Ming Wang; Rosemary Paschke; K Sudhindra Rao; Frank E Frerman; Jung-Ja P Kim
Journal:  Biochemistry       Date:  2004-08-03       Impact factor: 3.162

7.  Antenatal diagnosis of glutaric acidemia.

Authors:  S I Goodman; D A Gallegos; C J Pullin; B Halpern; R J Truscott; G Wise; B Wilcken; E D Ryan; D T Whelen
Journal:  Am J Hum Genet       Date:  1980-09       Impact factor: 11.025

8.  Predicting the functional impact of protein mutations: application to cancer genomics.

Authors:  Boris Reva; Yevgeniy Antipin; Chris Sander
Journal:  Nucleic Acids Res       Date:  2011-07-03       Impact factor: 16.971

9.  Clinical, biochemical, neuroradiological and molecular characterization of Egyptian patients with glutaric acidemia type 1.

Authors:  Hatem Zayed; Hamed El Khayat; Hoda Tomoum; Ola Khalifa; Ehab Siddiq; Shaimaa A Mohammad; Radwa Gamal; Zumin Shi; Ahmed Mosailhy; Osama K Zaki
Journal:  Metab Brain Dis       Date:  2019-05-06       Impact factor: 3.584

10.  PIC: Protein Interactions Calculator.

Authors:  K G Tina; R Bhadra; N Srinivasan
Journal:  Nucleic Acids Res       Date:  2007-06-21       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.